Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma

Key Points

M2BPGi serves as a strong indicator of recurrence in hepatocellular carcinoma after hepatectomy, with potential clinical use.
The biomarker shows minimal heterogeneity across studies, enhancing its reliability in clinical settings.
Utilizing preoperative serum levels of M2BPGi allows for easy measurement, simplifying monitoring procedures.
A robust association with recurrence risk emphasizes the importance of accurate biomarker detection in managing HCC.

Abstract

Preoperative serum M2BPGi is a promising biomarker for HCC recurrence after hepatectomy. Its strong association with risk, minimal heterogeneity across studies, and ease of measurement support its potential clinical utility.

Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma

Key Points

Abstract

Cite This Study